![More accurate prognostic prediction in diffuse large B-cell lymphoma: beyond cell-of-origin - Annals of Oncology More accurate prognostic prediction in diffuse large B-cell lymphoma: beyond cell-of-origin - Annals of Oncology](https://www.annalsofoncology.org/cms/asset/6ea215a0-50b3-4dd7-9679-dab0ad4a17af/gr1.jpg)
More accurate prognostic prediction in diffuse large B-cell lymphoma: beyond cell-of-origin - Annals of Oncology
![Hemato | Free Full-Text | Diffuse Large B-Cell Lymphoma: Recognition of Markers for Targeted Therapy Hemato | Free Full-Text | Diffuse Large B-Cell Lymphoma: Recognition of Markers for Targeted Therapy](https://pub.mdpi-res.com/hemato/hemato-02-00017/article_deploy/html/images/hemato-02-00017-ag-550.jpg?1622095529)
Hemato | Free Full-Text | Diffuse Large B-Cell Lymphoma: Recognition of Markers for Targeted Therapy
![Intra-tumour heterogeneity of diffuse large B-cell lymphoma involves the induction of diversified stroma-tumour interfaces - eBioMedicine Intra-tumour heterogeneity of diffuse large B-cell lymphoma involves the induction of diversified stroma-tumour interfaces - eBioMedicine](https://www.thelancet.com/cms/attachment/b2bb435b-74bf-4d4d-91e9-0bab8a36895b/gr1_lrg.jpg)
Intra-tumour heterogeneity of diffuse large B-cell lymphoma involves the induction of diversified stroma-tumour interfaces - eBioMedicine
![Molecular profiling in diffuse large B‐cell lymphoma: why so many types of subtypes? - Morin - 2022 - British Journal of Haematology - Wiley Online Library Molecular profiling in diffuse large B‐cell lymphoma: why so many types of subtypes? - Morin - 2022 - British Journal of Haematology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/de85ec9b-1453-445a-b180-d1874c741c17/bjh.v196.4.cover.jpg?trick=1673096986327)
Molecular profiling in diffuse large B‐cell lymphoma: why so many types of subtypes? - Morin - 2022 - British Journal of Haematology - Wiley Online Library
![Hemato | Free Full-Text | Diffuse Large B-Cell Lymphoma: Recognition of Markers for Targeted Therapy Hemato | Free Full-Text | Diffuse Large B-Cell Lymphoma: Recognition of Markers for Targeted Therapy](https://www.mdpi.com/hemato/hemato-02-00017/article_deploy/html/images/hemato-02-00017-g002.png)
Hemato | Free Full-Text | Diffuse Large B-Cell Lymphoma: Recognition of Markers for Targeted Therapy
C-MYC Aberrations as Prognostic Factors in Diffuse Large B-cell Lymphoma: A Meta-Analysis of Epidemiological Studies | PLOS ONE
![The rapidly changing landscape in mature T‐cell lymphoma (MTCL) biology and management - Marchi - 2020 - CA: A Cancer Journal for Clinicians - Wiley Online Library The rapidly changing landscape in mature T‐cell lymphoma (MTCL) biology and management - Marchi - 2020 - CA: A Cancer Journal for Clinicians - Wiley Online Library](https://acsjournals.onlinelibrary.wiley.com/cms/asset/5ff6c5b9-1afc-40b4-80c4-0bfb26b57011/caac21589-fig-0001-m.jpg)
The rapidly changing landscape in mature T‐cell lymphoma (MTCL) biology and management - Marchi - 2020 - CA: A Cancer Journal for Clinicians - Wiley Online Library
Factors related to the relative survival of patients with diffuse large B-cell lymphoma in a population-based study in France: does socio-economic status have a role? | Haematologica
![PDF) Evaluation of BCL-6, CD10, CD138 and MUM-1 expression in diffuse large B-cell lymphoma patients: CD138 is a marker of poor prognosis | Ismail Matalka - Academia.edu PDF) Evaluation of BCL-6, CD10, CD138 and MUM-1 expression in diffuse large B-cell lymphoma patients: CD138 is a marker of poor prognosis | Ismail Matalka - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/40033686/mini_magick20190222-21889-1hme795.png?1550825548)
PDF) Evaluation of BCL-6, CD10, CD138 and MUM-1 expression in diffuse large B-cell lymphoma patients: CD138 is a marker of poor prognosis | Ismail Matalka - Academia.edu
![Prognostic molecular biomarkers in diffuse large B-cell lymphoma in the rituximab era and their therapeutic implications - Sotirios G. Papageorgiou, Thomas P. Thomopoulos, Ioannis Katagas, Anthi Bouchla, Vassiliki Pappa, 2021 Prognostic molecular biomarkers in diffuse large B-cell lymphoma in the rituximab era and their therapeutic implications - Sotirios G. Papageorgiou, Thomas P. Thomopoulos, Ioannis Katagas, Anthi Bouchla, Vassiliki Pappa, 2021](https://journals.sagepub.com/cms/10.1177/20406207211013987/asset/images/large/10.1177_20406207211013987-fig3.jpeg)
Prognostic molecular biomarkers in diffuse large B-cell lymphoma in the rituximab era and their therapeutic implications - Sotirios G. Papageorgiou, Thomas P. Thomopoulos, Ioannis Katagas, Anthi Bouchla, Vassiliki Pappa, 2021
![Diagnostic and predictive biomarkers for lymphoma diagnosis and treatment in the era of precision medicine | Modern Pathology Diagnostic and predictive biomarkers for lymphoma diagnosis and treatment in the era of precision medicine | Modern Pathology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fmodpathol.2016.92/MediaObjects/41379_2016_Article_BFmodpathol201692_Fig1_HTML.jpg)